Navigation Links
Maryville, Tennessee based Molecular Pathology Laboratory Network, Inc. (MPLN) Acquires the First FDA Approved High-Throughput DNA Sequencing Analyzer
Date:12/2/2013

Maryville, TN (PRWEB) December 02, 2013

Molecular Pathology Laboratory Network, Inc. (MPLN) announced today that it has acquired the Illumina MiSeqDx™, currently the only next generation sequencing system approved by the US Food and Drug Administration (FDA). MPLN will be the first laboratory in the country to own the FDA approved version of this revolutionary technology, and will leverage the system for the expansion of testing across all of its clinical laboratories including its clinical trials group Geneuity Clinical Research Services.

This exciting new technology is capable of screening numerous gene targets simultaneously at a fraction of today’s costs and does so with phenomenally high throughput. MPLN, a molecular reference laboratory specializing in Oncology, Women’s Health, and clinical research services, will utilize the Illumina MiSeqDx™ to offer physicians greater access to clinically actionable data at the gene level, and ultimately the facilitation of better patient outcomes.

“We are proud to soon host this revolutionary technology in-house and be the first lab in the country to offer such comprehensive DNA sequencing analysis,” said Dr. Roger Hubbard, MPLN Chief Executive Officer. “The Illumina MiSeqDx™ truly enhances our ability to offer the most comprehensive testing services personalized to the level of each person’s unique genetic make-up.”

About Molecular Pathology Laboratory Network, Inc.
Located in Maryville, Tennessee and with a branch laboratory in Richmond, Virginia, MPLN delivers an incomparable and unique client experience by offering the most comprehensive services and innovative technologies in laboratory medicine. Providing an expanding menu of molecular diagnostics, specialty anatomic pathology, flow cytometry, and cytogenetic testing, MPLN is dedicated to providing superior diagnostic services to their clients in pathology groups, hospitals, medical laboratories and physician groups nationwide.MPLN specializes in oncology and women's health testing, and excels by utilizing highly qualified physicians, innovative technologies, all backed by unparalleled service to meet diagnostic challenges in a timely, cost-effective manner.

Read the full story at http://www.prweb.com/releases/2013/11/prweb11370342.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Basketball Legend Pat Summitt Leaving as Tennessee Womens Coach
2. The Tennessee Car Accident Lawyers at Michael D. Ponce & Associates Alert Public of CDC Survey Revealing Majority of High School Seniors Admitting to Texting Behind Wheel
3. IQware Solutions is Pleased to Announce that IQware MTM has Been Selected by the Tennessee Pharmacists Research and Education Foundation (TPREF)
4. University of Tennessee study: Unexpected microbes fighting harmful greenhouse gas
5. Tennessee Dental Association and Succeed Management Solutions Partner to Deliver New Safety Software Solution for Tennessee Dentists
6. AED.com Donates LifePak CR Plus AED to Tennessee State University Athletic Department
7. University of Tennessee researcher finds first time could predict sexual satisfaction
8. Tennessee Hospitals Take Aim at Medical Error with Aerial Aces
9. Dr. Stephen Lazarus Is a Plastic Surgeon and Expert Injector in Knoxville, Tennessee, Offering New SkinMedica Skin Brightening Product, Lytera
10. Smith & Nephew Hip Recall News: Bernstein Liebhard LLP Notes Motion to Consolidate Smith & Nephew Lawsuits Filed in Tennessee State Courts
11. Middle Tennessee Pest Control Experts U.S. Pest Protection Launch Mobile Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... ... 05, 2016 , ... As renowned, board-certified dermatologists, Dr. Sabrina G. Fabi and ... who do not do their research and undergo cosmetic dermatology treatments from unqualified practitioners ... of a renaissance and every other month a new treatment or device is launched, ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... called the CardioQuick Patch® significantly improves the reproducibility and accuracy of placing precordial ... healthcare settings. , Over the last 60 years, studies have shown that ...
(Date:12/4/2016)... ... 03, 2016 , ... While James Earl Jones is known for myriad roles ... show called "Front Page". One of the forthcoming episodes examines mammogram techniques; a very ... in large part due to early detection. Like any other disease, treatments have a ...
(Date:12/4/2016)... CA (PRWEB) , ... December 04, 2016 , ... ... without undergoing major cosmetic surgery can now take advantage of a cosmetic procedure ... advanced skin rejuvenation treatment that reduces the appearance of age spots, fine ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in ... Conference Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New ... Cohen, who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... innovative, personalized cell-based treatment for a high-risk form of the most common ... Hospital of Philadelphia today reported new results using ... The physician-scientists presented findings at the annual meeting of the American ... Continue Reading ... ...
(Date:12/2/2016)... , Dec 2, 2016 Research and Markets ... newsletter to their offering. ... , , R&D Drug ... Publishing,s proprietary R&D Drug Pipeline Database provides 24/7 online access to ... on the market and on investigational drug candidates in research & ...
(Date:12/2/2016)... Columbia , December 2, 2016 - bioLytical lanza el ... nuevas directrices de la OMS     Continue Reading ... ... , , ... enfermedades infecciosas, ha anunciado hoy que está expandiendo el lanzamiento de su INSTI ...
Breaking Medicine Technology: